Written Question·Department of Health and Social Care·UIN 112057

Life Sciences

Tabled: 9 February 2026

Answered: 17 February 2026

Question

Gregory Stafford

To ask the Secretary of State for Health and Social Care, what consideration has been given to the role of the generic and biosimilar medicines sector in shaping life sciences policy, in the context of it supplying around 85% of NHS prescription drugs by

Answer

Dr Zubir Ahmed

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 112057) →